Efficacy of Valacyclovir vs Acyclovir for the Prevention of Recurrent Herpes Simplex Virus Eye Disease: A Pilot Study

American Journal of Ophthalmology

Volumn 144, Issue 4, 2007, Pages

  Miserocchi, Elisabetta ^a   Modorati, Giulio ^a   Galli, Laura ^b   Rama, Paolo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; VALACICLOVIR;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; EYE DISEASE; FEMALE; HAIR LOSS; HEADACHE; HERPES SIMPLEX; HUMAN; IMMUNOCOMPETENCE; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT DURATION; VIRAL CONJUNCTIVITIS; VIRUS KERATITIS; VOMITING;

EID: 34548768837     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.06.001     Document Type: Article

References (23)

1. Liesegang T.J., Melton L.J., Daly P.J., and Ilstrup D.M. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 107 (1989) 1155-1159
2. Liesegang T.J. Herpes simplex virus epidemiology and ocular importance. Cornea 20 (2001) 1-13
3. Labetoulle M., Auquier P., Conrad H., et al. Incidence of herpes simplex keratitis in France. Ophthalmology 112 (2005) 888-895
4. Liesegang T.J. Classification of herpes simplex virus keratitis and anterior uveitis. Cornea 18 (1999) 127-143
5. Kaplowitz L.G., Baker D., Gelb L., et al. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. JAMA 265 (1991) 747-751
6. Baker D.A. Long-term suppressive therapy with acyclovir for recurrent genital herpes. J Int Med Res 22 (1994) 24A-32A
7. Stanberry L., Cunningham A., Mertz G., et al. New developments in the epidemiology, natural history and management of genital herpes. Antiviral Res 42 (1999) 1-14
8. Rooney J.F., Straus S.E., Mannix M.L., et al. Oral acyclovir to suppress frequently recurrent herpes labialis: a double-blind, placebo-controlled trial. Ann Intern Med 118 (1993) 268-272
9. Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 339 (1998) 300-306
10. Herpetic Eye Disease Study Group. Oral acyclovir for herpes simplex virus eye disease. Effect on prevention of epithelial keratitis and stromal keratitis. Arch Ophthalmol 118 (2000) 1030-1036
11. Uchoa U.B., Rezende R.A., Carrasco M.A., Rapuano C.J., Laibson P.R., and Cohen E.J. Long-term acyclovir use to prevent recurrent ocular herpes simplex virus infection. Arch Ophthalmol 121 (2003) 1702-1704
12. Beutner K.R. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antiviral Res 28 (1995) 281-290
13. Wilhelmus K.R., Falcon M.G., and Jones B.R. Herpetic iridocyclitis. Int Ophthalmol 4 (1982) 143-150
14. Wishart M.S., Darougar S., and Viswalingam N.D. Recurrent herpes simplex virus ocular infection: epidemiological and clinical features. Br J Ophthalmol 71 (1987) 669-672
15. Fife K.H., Crumpacker C.S., Mertz G.J., Hill E.L., Boone G.S., and Acyclovir Study Group. Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir. J Infect Dis 169 (1994) 1338-1341
16. Colin J., Prisant O., Cochener B., Lescale O., Rolland B., and Hoang-Xuan T. Comparison of the efficacy and safety of valacyclovir and acyclovir for the treatment of herpes zoster ophthalmicus. Ophthalmology 107 (2000) 1507-1511
17. Baker D.A., Blythe J.G., and Miller J.M. Once-daily valacyclovir hydrochloride for suppression of recurrent genital herpes. Obstet Gynecol 94 (1999) 103-106
18. Corey L., Wald A., Patel R., et al. Once daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 350 (2004) 11-20
19. Spruance S.L., Tyring S.K., DeGregorio B., Miller C., Beutner K., and Valacyclovir HSV Study Group. A large-scale, placebo-controlled, dose-ranging trial of peroral valacyclovir for episodic treatment of recurrent herpes genitalis. Arch Intern Med 156 (1996) 1729-1735
20. Miserocchi E., Waheed N.K., Dios E., et al. Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. Ophthalmology 109 (2002) 1532-1537
21. Rezende R.A., Bisol T., Hammersmith K., et al. Efficacy of oral antiviral prophylaxis in preventing ocular herpes simplex virus recurrences in patients with and without self-reported atopy. Am J Ophthalmol 142 (2006) 563-567
22. Murphy J., and Coster G. Issues in patient compliance. Drugs 54 (1997) 797-800
23. Lairson D.R., Begley C.E., Reynolds T.F., and Wilhelmus K.R. Prevention of herpes simplex virus eye disease. A cost-effectiveness analysis. Arch Ophthalmol 121 (2003) 108-112